Synthesis and antileishmanial activity of 3-imidazolylalkylindoles. Part I

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 19, Issue 6, 2004, Pages 451-457

  Na, Young Min ^a   Lebouvier, Nicolas ^b   Le Borgne, Marc ^b   Pagneiz, Fabrice ^b   Alvarez, Nidia ^b   Le Pape, Patrice ^b   Le Baut, Guillaume ^b  

^a Yang Ji Chemical Co Ltd   (South Korea)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Amastigotes; Azoles; Indoles; Leishmania mexicana; Promastigotes

Indexed keywords

1 (2 BROMOBENZYL) 3 (1H IMIDAZOL 1 YLMETHYL) 1H INDOLE; 1 (2 BROMOBENZYL) 3 FORMYL 1H INDOLE; 1 (2 BROMOBENZYL) 3 HYDROXYMETHYL 1H INDOLE; 1 (4 CHLOROBENZYL) 3 (1 HYDROXY 2 METHYLPROP 1 YL) 1H INDOLE; 5 FLUORO 3 FORMYL 1H INDOLE; ALLOPURINOL; AMPHOTERICIN B; ANTIFLAGELLATE AGENT; ANTILEISHMANIAL AGENT; IMIDAZOLE DERIVATIVE; IMIQUIMOD; INDOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MEGLUMINE ANTIMONATE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE; SITAMAQUINE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CHEMICAL PROCEDURES; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; LEISHMANIA MEXICANA; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; FIBROBLASTS; HUMANS; INDOLES; KETOCONAZOLE; LEISHMANIA MEXICANA; MACROPHAGES, PERITONEAL; MEGLUMINE; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; PARASITIC SENSITIVITY TESTS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

LEISHMANIA MEXICANA;

EID: 11244256535     PISSN: 14756366     EISSN: None     Source Type: Journal    
DOI: 10.1080/14756360412331280509     Document Type: Article

References (27)

1. Berman, J.D. (1997) Clin. Infect. Dis. 24, 684-703.
2. Khaw, M. and Panosian, C. (1995) Clin. Microbiol. Rev. 8, 427-439.
3. Bhadra, R. (1993) Drugs Fut. 18, 451-463.
4. Albar, J., Canavate, C., Gutierrez-Solar, B., Jimenez, M., Laguna, F., Lopez-Velez, R. and Moreno, J. (1997) Clin. Microb. Rev. 10, 298-319.
5. Olliaro, P. and Bryceson, A.D.M. (1993) Parasitol. Today 9, 323-328.
6. Farrell, J. (2002) World Class Parasites 4, 115-136.
7. Di Giorgio, C., Faraut-Gambarelli, F., Imbert, A., Minodier, P., Gasquet, M. and Dumon, H. (1999) J. Antimicrob. Chemother. 44, 71-76.
8. Davidson, R.N. and Croft, S.L. (1993) Trans. R. Soc. Trop. Med. Hygiene 87, 130-131.
9. Yardley, V. and Croft, S.L. (2000) Int. J. Antimicrob. Agents 13, 243-248.
10. Thakur, C.P. (2001) Int. J. Antimicrob. Agents 17 67-70.
11. Yardley, V. and Croft, S.L. (2000) Int. J. Antimicrob. Agents 13, 243-248.
12. Thakur, C.P. (2001) Int. J. Antimicrob. Agents 17 67-70.
13. Croft, S.L. and Coombs, G.H. (2003) Trends Parasitol. 11, 502-508.
14. Murray, H.W. (2001) Antimicrob. Agents Chemother. 45 2185-2197.
15. Berman, J.D., Goad, L.J., Beach, D.H. and Holz, G.G., Jr. (1986) Mol. Biochem. Parasitol. 20, 85-92.
16. Wali, J.P., Aggarwal, P., Gupta, U., Saluja, S. and Singh, S. (1992) J. Infect. Dis. 166, 214-215.
17. Rashid, J.R., Wasunna, K.M., Gachihi, G.S., Nyakundi, P.M., Mbugua, J. and Kirigi, G. (1994) East Afr. Med. J. 71, 392-395.
18. Dogra, J. and Saxena, V.N. (1996) Int. J. Parasitol. 26, 1413-1415.
19. Momeni, A.Z., Jalayer, T., Emamjomeh, M., Bashardost, N., Ghassemi, R.L., Meghdadi, M., Javadi, A. and Aminjavaheri, M. (1996) Arch. Dermatol. 132, 784-786.
20. Marchand, P., Le Borgne, M., Na, Y.M., Pagniez, E, Abdala, H., Le Baut, G. and Le Pape, P. (2002) J. Enzyme Inhib. Med. Chem. 17, 353-358.
21. James, P.N. and Snyder, H.R. (1959) Org. Synth. 39 30-33.
22. Na, Y.M., Le Borgne, M., Pagniez, F., Le Baut, G. and Le Pape, P. (2003) Eur. J. Med. Chem. 38, 75-87.
23. Berman, J.D. and Wyler, D. (1980) J. Inf. Dis. 142 83-86.
24. Katiyar, J.C., Anuradha and Sharma, S. (1992) Med. Res. Rev. 12, 473-504.
25. Abdala, H., Robert, J-M., Le Pape, P., Wielgosz, G., Robert-Piessard, S. and Le Baut, G. (2000) Arzn.-Forsch./Drug Res. 50(I), 479-484.
26. Pagniez, F. and Le Pape, P. (2001) J. Mycol. Médic. 11, 73-78.
27. Njar, V.C.O. (2000) Synthesis, 2019-2028.